Overhaul of MSK research needed

Funding for musculoskeletal (MSK) clinical trials in Australia is disproportionately low and many trials are not addressing the most critical issues, according to a new analysis.

While MSK conditions are the leading contributor to Australia’s disability burden, they attract only 0.8% of grants and funding from the National Health and Medical Research Council, the report published this week in the Medical Journal of

Latest

Trending